VapingNCT04899999
Graphic Messages to Prevent E-Cigarette Use Among Black and Latino Adolescents
A study testing Financial reward graphic message, Health reward graphic message and Self-efficacy graphic message in people with Vaping, run by University of Rochester at 1 site in United States.
Trial summary
The aim of this study is to determine if graphic messages prevent future vaping use among African American and Latino adolescents. The images have been developed in a user-design model and include four main themes: health reward, financial reward, self-efficacy, and social norms. Read more about this study
- Who is it for?
- Ages 12 to 17 yearsHealthy volunteers can take part
- Conditions the study is for
- Vaping
- What is being tested?
- Financial reward graphic message, Health reward graphic message and Self-efficacy graphic message
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 362 participants
- Where
- 1 siteUnited States
- Study dates
- 6 Aug 2021to 15 Dec 2021
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- self-identify as African American/Black and/or Hispanic/Latino
- know how to read and speak English and/or Spanish
- have never used e-cigarettes
- have access to a device that will be able to connect to the online survey
Who cannot join
- not identifying as African American/Black and/or Hispanic/Latino
- using e-cigarettes
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Rochester Medical Center
Rochester, New York, 14642
About this study
Official title: Graphic Messages to Prevent E-Cigarette Use Among Latino and African American Adolescents: A Randomized Controlled Trial
The aim of this study is to determine if graphic messages prevent future vaping use among African American and Latino adolescents. The images have been developed in a user-design model and include four main themes: health reward, financial reward, self-efficacy, and social norms. We will assess pre- and post-exposure reactions on likelihood of future vaping among African American and Latino adolescents.
- Conditions
- Vaping
- Being tested
- Financial reward graphic message, Health reward graphic message, Self-efficacy graphic message, Social norms graphic message
- Medical subject headings
- Vaping
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Financial reward graphic messageBehavioural
Graphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Vaping leads to nothing. Don't let your money vaporize away.
Health reward graphic messageBehavioural
Graphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Dying for a vape? It hurts more than you know.
Self-efficacy graphic messageBehavioural
Graphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Vaping companies are targeting Black and Latino teens. Your life matters. Don't let them take it away.
Social norms graphic messageBehavioural
Graphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Just because vaping is common, doesn't mean it's cool. Stay woke. Don't smoke.
| Study group | Role | What they receive |
|---|---|---|
| Financial reward graphic message | Experimental | Not described Receives: Behavioral: Financial reward graphic message |
| Health reward graphic message | Experimental | Not described Receives: Behavioral: Health reward graphic message |
| Self-efficacy graphic message | Experimental | Not described Receives: Behavioral: Self-efficacy graphic message |
| Social norms graphic message | Experimental | Not described Receives: Behavioral: Social norms graphic message |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Percentage of Participants Susceptible to Future Vaping
Susceptibility to future vaping was assessed before and after exposure to the graphic messages. Informed by prior foundational research on youth electronic cigarette use, susceptibility was measured with three items assessing curiosity, intent, and social influence. Participants were asked, "Have you ever been curious about using e-cigarettes/vaping?", "Do you think that you will use e-cigarettes/vape in the next 12 months?", and "If one of your best friends were to offer you an e-cigarette/electronic vapor product, would you use it?" (1 = "Definitely not" to 4 = "Definitely yes"). Responses were dichotomized: participants were categorized as susceptible if they answered anything other than "Definitely not" to at least one item. The percentage of susceptible participants was calculated before and after exposure; change in percentage reflects the difference.
Measured: baseline to post-intervention, approximately 1 day
Secondary outcomes (2)
Percentage of Participants Satisfied or Very Satisfied With the Graphic Message
Satisfaction with the assigned vaping prevention graphic message was assessed using the item: "How satisfied are you with the image?" Responses were recorded on a 5-point Likert scale from 1 = "Extremely unsatisfied" to 5 = "Extremely satisfied." Participants selecting 5 ("Extremely satisfied") were categorized as satisfied. The percentage of satisfied participants was calculated per group. Higher percentages indicate greater satisfaction with the message.
Measured: Day 1
Percent of Participants Who Would Recommend the Graphic Message to a Friend
participants were asked, "Would you recommend this picture to a friend?" with response options of Yes or No. The percentage of participants who responded "Yes" was calculated per group. Higher percentages indicate greater endorsement of the message.
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2021
- Study start6 Aug 2021
- Primary completion15 Dec 2021
- Study completion15 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for VapingStudies of the same condition, open and under way.
- More trials run by University of RochesterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 362 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Rochester
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Principal investigator, Francisco Cartujano, MD, University of Rochester
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04899999
- Sponsor's protocol ID
- STUDY00006267
- Other IDs
- U54CA228110
- Status last verified
- Feb 2022
- First submitted
- 19 May 2021
- Last updated
- 1 Aug 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Graphic Messages to Prevent E-Cigarette Use Among Latino and African American Adolescents: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT04899999
- Acronym / sponsor ID
- STUDY00006267
- Conditions
- Vaping
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 362 participants (actual)
- Lead sponsor
- University of RochesterUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 6 Aug 2021 (actual)
- Primary completion
- 15 Dec 2021 (actual)
- Study completion
- 15 Dec 2021 (actual)
- First posted
- 25 May 2021 (actual)
- Results
- Posted 1 Aug 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to determine if graphic messages prevent future vaping use among African American and Latino adolescents. The images have been developed in a user-design model and include four main themes: health reward, financial reward, self-efficacy, and social norms. We will assess pre- and post-exposure reactions on likelihood of future vaping among African American and Latino adolescents.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Financial reward graphic message | Experimental | Behavioral: Financial reward graphic message |
| Health reward graphic message | Experimental | Behavioral: Health reward graphic message |
| Self-efficacy graphic message | Experimental | Behavioral: Self-efficacy graphic message |
| Social norms graphic message | Experimental | Behavioral: Social norms graphic message |
Who may qualify
- Ages
- 12 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- self-identify as African American/Black and/or Hispanic/Latino
- know how to read and speak English and/or Spanish
- have never used e-cigarettes
- have access to a device that will be able to connect to the online survey
Key exclusion criteria (2 listed)
- not identifying as African American/Black and/or Hispanic/Latino
- using e-cigarettes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Financial reward graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Vaping leads to nothing. Don't let your money vaporize away. | Behavioural | Financial reward graphic message |
| Health reward graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Dying for a vape? It hurts more than you know. | Behavioural | Health reward graphic message |
| Self-efficacy graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Vaping companies are targeting Black and Latino teens. Your life matters. Don't let them take it away. | Behavioural | Self-efficacy graphic message |
| Social norms graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Just because vaping is common, doesn't mean it's cool. Stay woke. Don't smoke. | Behavioural | Social norms graphic message |
Primary outcome
Change in Percentage of Participants Susceptible to Future Vaping
Time frame: baseline to post-intervention, approximately 1 day
Susceptibility to future vaping was assessed before and after exposure to the graphic messages. Informed by prior foundational research on youth electronic cigarette use, susceptibility was measured with three items assessing curiosity, intent, and social influence. Participants were asked, "Have you ever been curious about using e-cigarettes/vaping?", "Do you think that you will use e-cigarettes/vape in the next 12 months?", and "If one of your best friends were to offer you an e-cigarette/electronic vapor product, would you use it?" (1 = "Definitely not" to 4 = "Definitely yes"). Responses were dichotomized: participants were categorized as susceptible if they answered anything other than "Definitely not" to at least one item. The percentage of susceptible participants was calculated before and after exposure; change in percentage reflects the difference.
2 secondary outcomes
Percentage of Participants Satisfied or Very Satisfied With the Graphic Message
Time frame: Day 1
Percent of Participants Who Would Recommend the Graphic Message to a Friend
Time frame: Day 1
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Aug 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Vaping
Active, not recruiting
Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users
Tobacco Smoking, Vaping
Not yet recruitingPhase 1
PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis
Cigarette Smoking-Related Carcinoma
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
Active, not recruiting
Mindful Breaths: Mindfulness for Young Adult Vaping
Vaping Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Financial reward graphic message, Health reward graphic message and Self-efficacy graphic message in people with Vaping, run by University of Rochester at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 1 Aug 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Percentage of Participants Susceptible to Future Vaping (time frame: baseline to post-intervention, approximately 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2025.